By Sheeba M. | April 24, 2026
Legalization Signals Spark Risk-On Trading in Cannabis Equities
April 2026 is shaping up to be pivotal for U.S. cannabis policy. After months of stalled legislative action, fresh bipartisan interest in federal decriminalization has triggered a sharp repricing of the sector. Cannabis stocks are up 18-22% month-to-date, with renewed retail participation and institutional hedge fund positioning in high-conviction names.
What’s driving the momentum?
- Congressional committee signaling: The House Judiciary Committee signaled willingness to advance decriminalization measures before the 2026 midterm cycle
- Banking relief expectations: De facto banking access improvements under SAFE Act (Secure and Fair Enforcement) provisions are gaining bipartisan traction
- State-level momentum: 23 states now have some form of legalized cannabis—up from 20 in 2024
Valuation Reset Incoming
Current multiples on large-cap operators like Trulieve (EV/EBITDA ~5.2x) and Curaleaf (EV/EBITDA ~4.8x) remain well below regulated alcohol (8-10x) and pharma (12-15x) comparables. If federal legalization materializes, expect 30-40% multiple expansion as institutional money enters with normalized risk profiles.
However, this is a binary catalyst. Failure to advance legislation could trigger sharp pullbacks—retail enthusiasm can reverse quickly on regulatory disappointment.
Capital Allocation Watch
Large operators are already signaling acquisition appetite at current valuations. Verano Holdings management recently highlighted M&A optionality, and smaller regional players (Illinois, Massachusetts) are attractive consolidation targets. Expect announcements in Q2.
Bottom Line
This rally is policy-driven, not fundamentals-driven. Sector sentiment has shifted from doom-and-gloom to cautious optimism, but positions should reflect legalization risk. Quality operators with strong cash flows (Curaleaf, Cresco Labs) are safer bets than highly levered regional players betting on rapid federal approval.
Sources
- House Judiciary Committee — MORE Act legislative status
- Congress.gov — Federal cannabis policy tracker
- NORML — Policy advocacy and legalization timeline
Track cannabis stocks with the Weedstock Real-Time Tracker